Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KIMEL, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KIMEL, V. M.
(Chest. 1961;39:249-250.)
© 1961 American College of Chest Physicians

Resectional Therapy for Pulmonary Tuberculosis at Sunmount, 1950-1957, 807 Cases

V. Resectional Therapy for Pulmonary Tuberculosis under Viomycin and Pyrazinamide Coverage

VICTOR M. KIMEL M.D.

Thirty-two patients who had resectional therapy for pulmonary tuberculosis under viomycin and pyrazmnamide chemotherapy coverage have been reviewed. It is concluded that the experience at Sunmout testifies to the fact that viomycin and pyrazinamide represent satisfactory secondary chemotherapy coverage for pulmonary resections.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1961 by the American College of Chest Physicians.